Dashboard
Manage Tickers

IMVTImmunovant, Inc.

Nasdaq immunovant.com


$ 26.89 $ 0.69 (2.61 %)    

Friday, 05-Jul-2024 15:59:59 EDT
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 495.80 $ 5.12 (1.04 %)
DIA $ 393.71 $ 0.87 (0.22 %)
SPY $ 554.29 $ 3.18 (0.58 %)
TLT $ 92.56 $ 0.76 (0.83 %)
GLD $ 220.89 $ 2.94 (1.35 %)
$ 26.885
$ 26.09
$ 0.00 x 0
$ 0.00 x 0
$ 25.97 - $ 27.00
$ 18.16 - $ 45.58
603,169
na
3.71B
$ 1.27
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 05-29-2024 03-31-2024 10-K
2 02-12-2024 12-31-2023 10-Q
3 11-09-2023 09-30-2023 10-Q
4 08-10-2023 06-30-2023 10-Q
5 05-22-2023 03-31-2023 10-K
6 02-03-2023 12-31-2022 10-Q
7 11-04-2022 09-30-2022 10-Q
8 08-05-2022 06-30-2022 10-Q
9 06-08-2022 03-31-2022 10-K
10 02-04-2022 12-31-2021 10-Q
11 11-05-2021 09-30-2021 10-Q
12 08-09-2021 06-30-2021 10-Q
13 06-01-2021 03-31-2021 10-K
14 02-16-2021 12-31-2020 10-Q
15 11-12-2020 09-30-2020 10-Q
16 08-12-2020 06-30-2020 10-Q
17 06-29-2020 03-31-2020 10-K
18 02-14-2020 12-31-2019 10-Q
19 11-13-2019 09-30-2019 10-Q
20 08-12-2019 06-30-2019 10-Q
21 06-12-2019 03-31-2019 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

cantor-fitzgerald-reiterates-overweight-on-immunovant
Cantor Fitzgerald Reiterates Overweight on...
06/20/2024 17:36:27

Cantor Fitzgerald analyst Louise Chen reiterates Immunovant (NASDAQ:IMVT) with a Overweight.

cantor-fitzgerald-reiterates-overweight-on-immunovant
Cantor Fitzgerald Reiterates Overweight on...
06/18/2024 14:06:18

Cantor Fitzgerald analyst Louise Chen reiterates Immunovant (NASDAQ:IMVT) with a Overweight.

oppenheimer-maintains-outperform-on-immunovant-lowers-price-target-to-46
Oppenheimer Maintains Outperform on Immuno...
06/03/2024 12:26:25

Oppenheimer analyst Leland Gershell maintains Immunovant (NASDAQ:IMVT) with a Outperform and lowers the price target from $5...

cantor-fitzgerald-reiterates-overweight-on-immunovant
Cantor Fitzgerald Reiterates Overweight on...
05/30/2024 15:47:36

Cantor Fitzgerald analyst Louise Chen reiterates Immunovant (NASDAQ:IMVT) with a Overweight.

hc-wainwright--co-reiterates-buy-on-immunovant-maintains-51-price-target
HC Wainwright & Co. Reiterates Buy on Immu...
05/30/2024 11:25:01

HC Wainwright & Co. analyst Douglas Tsao reiterates Immunovant (NASDAQ:IMVT) with a Buy and maintains $51 price target.

12-health-care-stocks-moving-in-wednesdays-after-market-session
12 Health Care Stocks Moving In Wednesday'...
05/29/2024 20:31:09

immunovant-q4-eps-052-misses-043-estimate
Immunovant Q4 EPS $(0.52) Misses $(0.43) E...
05/29/2024 20:05:36

Immunovant (NASDAQ:IMVT) reported quarterly losses of $(0.52) per share which missed the analyst consensus estimate of $(0.43) ...

biohaven-stock-stumbles-as-protein-degrading-drug-falls-short-of-expectations-in-early-stage-study
Biohaven Stock Stumbles As Protein-Degradi...
05/29/2024 18:47:15

Biohaven shares drop as interim data from the Phase 1 study of BHV-1300 fell short of investor expectations.

why-bank-of-montreal-shares-are-trading-lower-by-around-7-here-are-other-stocks-moving-in-wednesdays-mid-day-session
Why Bank of Montreal Shares Are Trading Lo...
05/29/2024 17:28:35

heico-posts-upbeat-earnings-joins-surmodics-abercrombie--fitch-and-other-big-stocks-moving-higher-on-wednesday
Heico Posts Upbeat Earnings, Joins Surmodi...
05/29/2024 14:38:24

oppenheimer-initiates-coverage-on-immunovant-with-outperform-rating-announces-price-target-of-50
Oppenheimer Initiates Coverage On Immunova...
03/28/2024 10:49:49

Oppenheimer analyst Leland Gershell initiates coverage on Immunovant (NASDAQ:IMVT) with a Outperform rating and announces Pr...

truist-securities-reiterates-buy-on-immunovant-maintains-48-price-target
Truist Securities Reiterates Buy on Immuno...
03/25/2024 16:11:34

Truist Securities analyst Robyn Karnauskas reiterates Immunovant (NASDAQ:IMVT) with a Buy and maintains $48 price target.

12-health-care-stocks-moving-in-thursdays-pre-market-session
12 Health Care Stocks Moving In Thursday's...
03/21/2024 13:05:49

goldman-sachs-initiates-coverage-on-immunovant-with-buy-rating-announces-price-target-of-50
Goldman Sachs Initiates Coverage On Immuno...
03/13/2024 12:38:42

Goldman Sachs analyst Corinne Johnson initiates coverage on Immunovant (NASDAQ:IMVT) with a Buy rating and announces Price T...

immunovant-awarded-us-patent-for-imvt-1402
Immunovant Awarded U.S. Patent for IMVT-1402
03/12/2024 11:32:37

wolfe-research-initiates-coverage-on-immunovant-with-outperform-rating-announces-price-target-of-55
Wolfe Research Initiates Coverage On Immun...
02/15/2024 11:40:04

Wolfe Research analyst Andy Chen initiates coverage on Immunovant (NASDAQ:IMVT) with a Outperform rating and announces Price...

recap-immunovant-q3-earnings
Recap: Immunovant Q3 Earnings
02/12/2024 13:00:06

immunovant-q3-eps-036-up-from-049-yoy-cash-and-cash-equivalents-totaled-approximately-691m
Immunovant Q3 EPS $(0.36) Up From $(0.49) ...
02/12/2024 12:11:54

Immunovant (NASDAQ:IMVT) reported quarterly losses of $(0.36) per share. This is a 26.53 percent increase over losses of $(0.49...

why-carmax-shares-are-trading-higher-by-around-8-here-are-other-stocks-moving-in-thursdays-mid-day-session
Why CarMax Shares Are Trading Higher By Ar...
12/21/2023 18:01:44

Shares of CarMax, Inc. (NYSE: KMX) moved higher during Thursday’s session following better-than-expected quarterly earnings.

b-of-a-securities-maintains-buy-on-immunovant-raises-price-target-to-51
B of A Securities Maintains Buy on Immunov...
12/21/2023 16:29:59

B of A Securities analyst Jason Gerberry maintains Immunovant (NASDAQ:IMVT) with a Buy and raises the price target from $49 ...

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

07/09/2024 Li Auto Inc. (LI)
07/12/2024 Inari Medical, Inc. (NARI)
07/12/2024 Sprout Social, Inc. (SPT)
07/15/2024 UnitedHealth Group Inc. (UNH)
07/16/2024 Teladoc Health, Inc. (TDOC)
07/16/2024 Vestis Corporation (VSTS)
07/22/2024 Cambium Networks Corporation (CMBM)
07/22/2024 Biogen Inc. (BIIB)
07/23/2024 Fastly, Inc. (FSLY)
07/29/2024 Enphase Energy, Inc. (ENPH)

NEW CASE INVESTIGATION

Ooma Inc (OOMA) AnaptysBio Inc (ANAB)